Literature DB >> 18424641

Apelin decreases the SR Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions during twitches in isolated rat cardiac myocytes.

Chen Wang1, Jun-Feng Du, Feng Wu, Hai-Chang Wang.   

Abstract

Apelin has been reported to have a positive inotropic action in the isolated rat heart. However, the effect of apelin on sarcoplasmic reticulum (SR) Ca2+ content and its influence on intracellular Ca2+ transient during excitation-contraction coupling remains poorly understood. In the present study, we determined the effect of apelin on Ca2+ transient and contractions in isolated rat cardiomyocytes. When compared with control, treatment with apelin caused a 55.7 +/- 13.9% increase in sarcomere fraction shortening and a 43.6 +/- 4.56% increase in amplitude of electrical-stimulated intracellular Ca2+ concentration (E[Ca2+]i) transients (n = 14, P < 0.05). But SR Ca2+ content measured by caffeine-induced [Ca2+]i (C[Ca2+]i) transient was decreased 8.41 +/- 0.92% in response to apelin (n = 14, P < 0.05). Na+/Ca2+ exchanger (NCX) function was increased since half-decay time of C[Ca2+]i was decreased 16.22 +/- 1.36% in response to apelin. Sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) activity was also increased by apelin. These responses can be partially or completely blocked by chelerythrine chloride, a PKC inhibitor. In addition, to confirm our data, we used indo-1 as another Ca2+ indicator and rapid cooling as another way to measure SR Ca2+ content, and we observed similar results. So we conclude that apelin has a positive inotropic effect on isolated myocytes, and increased amplitude of E[Ca2+]i is at least partially involved in the mechanism. NCX function and SERCA activity are increased by apelin, and the SR Ca2+ content is decreased by apelin during twitches. PKC played an important role in these signaling mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424641     DOI: 10.1152/ajpheart.00046.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  21 in total

1.  Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure.

Authors:  Mengjun Wang; Ramesh C Gupta; Sharad Rastogi; Smita Kohli; Michael S Sabbah; Kefei Zhang; Paula Mohyi; Manuela Hogie; Yvan Fischer; Hani N Sabbah
Journal:  J Card Fail       Date:  2013-07       Impact factor: 5.712

Review 2.  Cardioprotective apelin effects and the cardiac-renal axis: review of existing science and potential therapeutic applications of synthetic and native regulated apelin.

Authors:  Carina Ureche; Laura Tapoi; Simona Volovat; Luminita Voroneanu; Mehmet Kanbay; Adrian Covic
Journal:  J Hum Hypertens       Date:  2019-01-18       Impact factor: 3.012

Review 3.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

4.  Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes.

Authors:  Shunming Zhu; Fei Sun; Weijie Li; Yanjie Cao; Chen Wang; Yabin Wang; Dong Liang; Rongqing Zhang; Shenwei Zhang; Haichang Wang; Feng Cao
Journal:  Mol Cell Biochem       Date:  2011-04-02       Impact factor: 3.396

Review 5.  Effects of apelin on the cardiovascular system.

Authors:  Anna Folino; Pier Giorgio Montarolo; Michele Samaja; Raffaella Rastaldo
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

6.  Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition.

Authors:  Victoria N Parikh; Jing Liu; Ching Shang; Christopher Woods; Alex C Chang; Mingming Zhao; David N Charo; Zachary Grunwald; Yong Huang; Kinya Seo; Philip S Tsao; Daniel Bernstein; Pilar Ruiz-Lozano; Thomas Quertermous; Euan A Ashley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

7.  Modulation of canine cardiac sodium current by Apelin.

Authors:  Caroline Chamberland; Hector Barajas-Martinez; Volker Haufe; Marie-Hélène Fecteau; Jean-Francois Delabre; Alexander Burashnikov; Charles Antzelevitch; Olivier Lesur; Ahmed Chraibi; Philippe Sarret; Robert Dumaine
Journal:  J Mol Cell Cardiol       Date:  2009-12-28       Impact factor: 5.000

8.  Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.

Authors:  Seyyed M R Kazemi-Bajestani; Vaibhav B Patel; Wang Wang; Gavin Y Oudit
Journal:  Cardiol Res Pract       Date:  2012-05-13       Impact factor: 1.866

9.  Apelin enhances directed cardiac differentiation of mouse and human embryonic stem cells.

Authors:  I-Ning E Wang; Xiang Wang; Xiaohu Ge; Joshua Anderson; Michael Ho; Euan Ashley; Jianwei Liu; Manish J Butte; Masayuki Yazawa; Ricardo E Dolmetsch; Thomas Quertermous; Phillip C Yang
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

10.  Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice.

Authors:  Satvik Mareedu; Ronald Pachon; Jayapalraj Thilagavathi; Nadezhda Fefelova; Rekha Balakrishnan; Nandita Niranjan; Lai-Hua Xie; Gopal J Babu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-11-20       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.